Post-Allergan, Advanced Medical Optics Reviews Manufacturing Options
This article was originally published in The Gray Sheet
Executive Summary
Advanced Medical Optics' $22 mil. purchase of Alcon's eye care product factory in Madrid will replace manufacturing capacity that will be terminated when AMO ends its contract with Allergan within the next two years
You may also be interested in...
AMO Adds Glaucoma Device, Fills Cataract Line With $450 Mil. Pfizer Eye Unit
Advanced Medical Optics' purchase of Pfizer's surgical ophthalmology business bolsters its cataract surgery portfolio by adding viscoelastics and expanded intraocular lens (IOL) offerings
AMO Adds Glaucoma Device, Fills Cataract Line With $450 Mil. Pfizer Eye Unit
Advanced Medical Optics' purchase of Pfizer's surgical ophthalmology business bolsters its cataract surgery portfolio by adding viscoelastics and expanded intraocular lens (IOL) offerings
AMO Surgical Devices Outshine Lens Care Products In First Earnings Report
Advanced Medical Optics' sales of intraocular lenses and phacoemulsification devices supported an 8.2% increase in ophthalmic surgical device revenue in the second quarter - the period just prior to AMO's June 29 spin-off from Allergan